Differential Expression of Urokinase-Type Plasminogen Activator, Its Receptor, and Inhibitors in Mouse Skin After Exposure to a Tumor-Promoting Phorbol Ester

This publication has 44 references indexed in Scilit:

• Type‐2 plasminogen‐activator inhibitor is a substrate for trophoblast transglutaminase and Factor XIII_a
  European Journal of Biochemistry, 1993
• Interleukin‐1α gene expression and localization of interleukin‐1α protein during tumor promotion
  Molecular Carcinogenesis, 1993
• Identification and characterization of the murine cell surface receptor for the urokinase‐type plasminogen activator
  European Journal of Biochemistry, 1992
• Urokinase Plasminogen Activator Is Immunocytochemically Detectable in Squamous Cell but Not Basal Cell Carcinomas
  Journal of Investigative Dermatology, 1992
• TGF‐β1 and skin carcinogenesis: Antiproliferative effect in vitro and TGF‐β1 mRNA expression during epidermal hyperproliferation and multistage tumorigenesis
  Molecular Carcinogenesis, 1991
• Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate.
  The Journal of cell biology, 1989
• Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression
  Molecular Carcinogenesis, 1988
• Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate.
  The Journal of cell biology, 1986
• Comparison of three actin-coding sequences in the mouse; Evolutionary relationships between the actin genes of warm-blooded vertebrates
  Journal of Molecular Evolution, 1986
• Overview of tumor promotion in animals
  Environmental Health Perspectives, 1983